Shandong Sito Bio-technology Balance Sheet Health
Financial Health criteria checks 4/6
Shandong Sito Bio-technology has a total shareholder equity of CN¥2.1B and total debt of CN¥862.0M, which brings its debt-to-equity ratio to 41.6%. Its total assets and total liabilities are CN¥3.4B and CN¥1.3B respectively. Shandong Sito Bio-technology's EBIT is CN¥72.1M making its interest coverage ratio -20. It has cash and short-term investments of CN¥351.3M.
Key information
41.6%
Debt to equity ratio
CN¥861.99m
Debt
| Interest coverage ratio | -20x |
| Cash | CN¥351.28m |
| Equity | CN¥2.07b |
| Total liabilities | CN¥1.30b |
| Total assets | CN¥3.37b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300583's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥1.2B).
Long Term Liabilities: 300583's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥147.7M).
Debt to Equity History and Analysis
Debt Level: 300583's net debt to equity ratio (24.7%) is considered satisfactory.
Reducing Debt: 300583's debt to equity ratio has increased from 31.5% to 41.6% over the past 5 years.
Debt Coverage: 300583's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 300583 earns more interest than it pays, so coverage of interest payments is not a concern.